Clinical trial Recruiting at 1 site Observational Ages 16 to 80

Pigmentary glaucoma: does a 120° ab-interno trabeculotomy help

Official title: Clinical Characteristics of Pigmentary Glaucoma and Efficacy Analysis of Ab-interno 120° Trabeculotomy: A Case Series Study

Run by Zhongnan Hospital · NCT07713056 · Data updated 2026-11-12

This study will see if performing an ab-interno 120° trabeculotomy can lower eye pressure and reduce medication needs in people with pigmentary glaucoma over six months.

Quick facts

Study typeObservational
Ages16 Years to 80 Years
SexAll
Enrollment11 (estimated)
SponsorZhongnan Hospital
Academic / other
Locations1 site (Wuhan, Hubei)
StatusRecruiting
StartedApril 1, 2026
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2026
Registry record updatedJuly 20, 2026
Trial IDNCT07713056 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults diagnosed with pigmentary glaucoma who are undergoing primary, isolated ab-interno 120° trabeculotomy and have complete preoperative and at least six months of postoperative data.

Probably not a fit

Patients with exfoliation syndromes, other glaucoma types, ocular trauma, prior ocular surgeries, or those unable to complete six months of follow-up may not benefit or may be excluded from conclusions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, retrospective case series of pigmentary glaucoma patients treated with primary, isolated ab-interno 120° trabeculotomy at Zhongnan Hospital. Researchers will collect baseline demographics, eye exams, and prior treatments to describe typical features of pigmentary glaucoma. The primary endpoint is intraocular pressure at six months postoperatively, with secondary observations on medication use, visual field and RNFL stability, and any surgical complications. The goal is to provide clinical evidence to guide individualized surgical decisions for pigmentary glaucoma. The study does not involve a randomized control or prospective design.

Why it matters

Potential benefit: If successful, patients may experience lower eye pressure and reduced need for glaucoma medications after the procedure.

How similar studies have gone: Previous studies of similar angle-surgery approaches have shown varying success; this study adds data specific to pigmentary glaucoma in a retrospective, single-center setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Meet the clinical diagnostic criteria for pigmentary glaucoma, with typical signs of pigment dispersion syndrome, extensive trabecular meshwork pigmentation, pathological intraocular pressure elevation, glaucomatous optic nerve damage, and characteristic visual field defects;
* Underwent primary isolated ab-interno 120° trabeculotomy as the initial surgical treatment;
* Have complete preoperative and postoperative examination data, including slit-lamp biomicroscopy, gonioscopy, intraocular pressure, visual field, and OCT RNFL measurements;
* Able to complete regular follow-up for at least 6 months postoperatively.

Exclusion Criteria:

* Patients with exfoliation syndrome, exfoliative glaucoma, or other types of primary or secondary glaucoma;
* Patients with a history of ocular trauma, intraocular surgery, uveitis, severe retinopathy, or other ocular diseases affecting intraocular pressure and visual function assessment;
* Patients who underwent combined procedures such as concurrent cataract surgery or other anti-glaucoma surgeries during the operation;
* Patients with severe systemic diseases, cognitive or psychiatric disorders that prevent cooperation with examinations and follow-up;
* Patients with missing key clinical or follow-up data that preclude efficacy and prognosis evaluation.

Where it's running

  • Zhongnan Hospital of Wuhan University
    Wuhan, Hubei, China
    Recruiting

Study contacts

  • Principal investigator: Wen Zeng, doctor — Zhongnan Hospital
  • Study coordinator: Min Ke, doctor
  • Email: Keminyk@163.com
  • Phone: 18672395959

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.